Bayer Schering Pharma Paves The Way To The Next Important Oral Contraceptive Milestone

Bayer Schering Pharma AG, Germany, has submitted for registration the first combined oral contraceptive product based on estradiol and the progestin dienogest to all Member States of the European Community. The Netherlands will serve as the Reference Member State for the Decentralized Procedure to gain European-wide Marketing Authorization. This new oral contraceptive provides estradiol, the same estrogen produced by the female body. [click link for full article]

More: continued here

Filed under: Fertility on December 15th, 2007